FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy
Crossref DOI link: https://doi.org/10.1007/s12149-015-1038-7
Published Online: 2015-11-27
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kremer, Ran
Peysakhovich, Yury
Dan, Levy-Faber
Guralnik, Ludmila
Kagna, Olga
Nir, Rony-Reuven
Bar-Shalom, Rachel
Text and Data Mining valid from 2015-11-27